{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:23:41Z","timestamp":1787955821277,"version":"build-2784847793"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Croatian Society for Rheumatology","award":["0000"],"award-info":[{"award-number":["0000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objective: The most prominent feature of systemic sclerosis (SSc), besides vasculopathy and autoimmune disorders, is excessive fibrosis. Serotonin affects hemostasis and can induce vasoconstriction, which is presumed to be one of the pathophysiological patterns in SSc that leads to fibrosis. Our aim was to explore the possible association of serotonin with some of the clinical features of SSc in our cohort of patients. Materials and Methods: We measured serotonin levels in sera of 29 female SSc patients. Patients were 41\u201379 years old, their average disease duration was 9 years. Serotonin values were analyzed in correlation with clinical and laboratory parameters, such as modified Rodnan skin score (mRSS), digital ulcers (DU), and spirometry parameters-forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and lung diffusion capacity of carbon monoxide (DLCO). Statistical analyses were performed using statistical software Statistica. Results: We found correlation of serotonin level with mRSS (r = 0.388, p = 0.038). The highest values of serotonin were documented in patients with refractory DU, but this was not statistically significant. We also found a negative correlation between serotonin and FVC (r = \u22120.397), although it did not reach the level of significance (p = 0.114). Conclusions: Our study suggests that levels of serum serotonin could affect the course of skin fibrosis and partially restrictive pulmonary dysfunction in patients with SSc. We assume that serotonin might have influence on several features of SSc, but more studies are needed to reveal those relations.<\/jats:p>","DOI":"10.3390\/medicina58020161","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:37:18Z","timestamp":1642754238000},"page":"161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Levels of Serum Serotonin Can Be Related to Skin and Pulmonary Manifestations of Systemic Sclerosis"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-9633","authenticated-orcid":false,"given":"Marin","family":"Petri\u0107","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Hospital of Split, \u0160oltanska 1, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Perkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Hospital of Split, \u0160oltanska 1, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Bo\u017ei\u0107","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Hospital of Split, \u0160oltanska 1, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-8825","authenticated-orcid":false,"given":"Daniela","family":"Marasovi\u0107 Krstulovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Hospital of Split, \u0160oltanska 1, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161anka","family":"Martinovi\u0107 Kaliterna","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Hospital of Split, \u0160oltanska 1, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/16066350500095415","article-title":"New developments in the pathogenesis of systemic sclerosis","volume":"38","author":"Sakkas","year":"2005","journal-title":"Autoimmunity"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The Pathogenesis of Systemic Sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.13009","article-title":"Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients","volume":"190","author":"Guggino","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12026-017-8926-y","article-title":"Pathogenesis of systemic sclerosis-current concept and emerging treatments","volume":"65","author":"Furue","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","article-title":"Platelet contributions to the pathogenesis of systemic sclerosis","volume":"19","author":"Postlethwaite","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101428","DOI":"10.1016\/j.berh.2019.101428","article-title":"Very early systemic sclerosis","volume":"33","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.12968\/hmed.2019.80.11.658","article-title":"Raynaud\u2019s phenomenon","volume":"80","author":"Devgire","year":"2019","journal-title":"Br. J. Hosp. Med. (Lond.)"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_10","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2017.05.004","article-title":"The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis","volume":"47","author":"Ntelis","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0024-3205(97)01166-1","article-title":"Serotonin and vasoconstrictor synergism","volume":"62","author":"Yildiz","year":"1998","journal-title":"Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Soslau, G. (2021). Cardiovascular serotonergic system: Evolution, receptors, transporter, and function. J. Exp. Zool. Part A-Ecol. Integr. Physiol., Available online: https:\/\/www.webofscience.com\/wos\/woscc\/full-record\/WOS:000708131600001.","DOI":"10.1002\/jez.2554"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-96-5-610","article-title":"Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma","volume":"96","author":"Kahaleh","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1373\/clinchem.2011.163824","article-title":"The measurement of platelet-poor plasma serotonin: A systematic review of prior reports and recommendations for improved analysis","volume":"57","author":"Brand","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","article-title":"Platelet-derived serotonin links vascular disease and tissue fibrosis","volume":"208","author":"Dees","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.48.7.586","article-title":"Platelet serotonin in systemic sclerosis","volume":"48","author":"Klimiuk","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archinte.1973.00320100078010","article-title":"Scleroderma-like lesions and the carcinoid syndrome","volume":"131","author":"Fries","year":"1973","journal-title":"Arch. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3181\/00379727-97-23734","article-title":"Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate","volume":"97","author":"Macdonald","year":"1958","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0031-6989(85)90067-0","article-title":"Serotonin and vascular reactivity","volume":"17","author":"Janssens","year":"1985","journal-title":"Pharmacol. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(88)90238-0","article-title":"Plasma free and intraplatelet serotonin in patients with Raynaud\u2019s phenomenon","volume":"19","author":"Biondi","year":"1988","journal-title":"Int. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3899\/jrheum.091156","article-title":"Association study of serotonin transporter gene (SLC6A4) in systemic sclerosis in European Caucasian populations","volume":"37","author":"Wipff","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar2495","article-title":"A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation","volume":"10","author":"Beretta","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/ar2606","article-title":"5HT2A polymorphism His452Tyr in a German Caucasian systemic sclerosis population","volume":"11","author":"Kirsten","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/18715230113129990018","article-title":"Relationships between serotoninergic system and skin fibrotic","volume":"13","author":"Huang","year":"2014","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbadis.2012.09.009","article-title":"Serotonin paracrine signaling in tissue fibrosis","volume":"1832","author":"Mann","year":"2013","journal-title":"Biochim. Biophys Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1191\/1358863x05vm639ra","article-title":"Mechanisms of Raynaud\u2019s disease","volume":"10","author":"Cooke","year":"2005","journal-title":"Vasc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1249\/MSS.0000000000000907","article-title":"Exercise Reduces Lung Fibrosis Involving Serotonin\/Akt Signaling","volume":"48","author":"Pereira","year":"2016","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"438403","DOI":"10.1155\/2015\/438403","article-title":"5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure","volume":"2015","author":"Janssen","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1183\/09031936.00126907","article-title":"Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice","volume":"32","author":"Fabre","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"L\u00f6fdahl, A., Tornling, G., Wig\u00e9n, J., Larsson-Callerfelt, A.K., Wengl\u00e9n, C., and Westergren-Thorsson, G. (2020). Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010225"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12031-009-9320-6","article-title":"Identification of a potential molecular link between the glucocorticoid and serotonergic signaling systems","volume":"41","author":"Falkenberg","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jdi.12406","article-title":"Important role of 5-hydroxytryptamine in glucocorticoid-induced insulin resistance in liver and intra-abdominal adipose tissue of rats","volume":"7","author":"Li","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hasni Ebou, M., Singh-Estivalet, A., Launay, J.M., Callebert, J., Tronche, F., Ferr\u00e9, P., Gautier, J.F., Guillemain, G., Br\u00e9ant, B., and Blondeau, B. (2016). Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149343"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Fransen","year":"2017","journal-title":"Ann. Rheum. Dis."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:05:11Z","timestamp":1760133911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["medicina58020161"],"URL":"https:\/\/doi.org\/10.3390\/medicina58020161","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}